Celsion Corporation Announces Oral Presentation at International Vaccines Congress

NEXT STORY
Vaxil Announces Progress on Research and Development Activities
PREV STORY
Quotient Limited Announces Appointment of Chief Financial Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CorMedix Inc. of Class Action Lawsuit and Upcoming Deadline – CRMD

author_avatar
NASDAQ Market News

Leonhardt Ventures Announces Issuance of Pioneering U.S. Patent for Multi-Modality Customized Bioelectric Treatment of Cancer

author_avatar
NASDAQ Market News

Dyadic International Hosting a Fireside Chat on “The Potential of the Transformative Dyadic C1 Protein Technology in Helping Meet Global Health Challenges”

author_avatar
NASDAQ Market News